It is worth noting that single cell TCR sequencing confirmed that CTLA-4 inhibitor combined with PD-1 blocker synergistically enhanced the temporal and spatial dynamics of T cell clones, significantly improving the breadth and persistence of anti-tumor immunity [53]. This evidence concerns the gene CTLA4 and neoplasm.